Efficacy and Safety of a Cutaneous Formulation of Gonyautoxin 2/3 (GTX 2/3) for the Treatment of Facial Wrinkles

NCT00734786 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
15
Enrollment
INDUSTRY
Sponsor class

Stopped Study cancelled.

Conditions

Interventions

Sponsor

Phytotox SA